Archive - May 2020
How to Ride the Data Wave When Launching a New Drug
A Better Path to Payer Insights
Roche makes protein degradation play with $135m Vividion deal
Octapharma cleared to start phase 3 trial of Octagam in COVID-19
COVID-19 Update: FDA Approves Phase 3 Clinical Trial For Octagam For Severe Cases
UK government expands coronavirus testing criteria
How to Ride the Data Wave When Launching a New Drug
Researchers investigate impact of lockdown on musculoskeletal conditions